Lexicon Pharmaceuticals (LXRX) Return on Sales Growth (1y) (2011 - 2026)
Lexicon Pharmaceuticals (LXRX) Return on Sales Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 940.52 Mn | 769.87 Mn | 20.99 Mn | 22.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.00 |
| Dec 31, 2025 | -2.00 |
| Sep 30, 2025 | 38.00 |
| Jun 30, 2025 | 35.00 |
| Mar 31, 2025 | 23.00 |
| Dec 31, 2024 | 67.00 |
| Sep 30, 2024 | 331.00 |
| Jun 30, 2024 | 142.00 |
| Mar 31, 2024 | 3,222.00 |
| Dec 31, 2023 | 2,937.00 |
| Sep 30, 2023 | 2,470.00 |
| Jun 30, 2023 | 571.00 |
| Sep 30, 2022 | -2,499.00 |
| Jun 30, 2022 | -938.00 |
| Sep 30, 2021 | -334.00 |
| Jun 30, 2021 | 3,001.00 |
| Mar 31, 2021 | -55.00 |
| Dec 31, 2020 | -22.00 |
| Sep 30, 2020 | -7.00 |
| Jun 30, 2020 | -2,783.00 |